Title XELOX FOR SALIVARY GLAND CANCERS

Clinical trial NCT00101075 · TERMINATED

Trial details

NCT number: NCT00101075
Sponsor: Dana-Farber Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2004-10-01
Primary completion: 2007-03-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.